Related Experiment Video

Updated: May 17, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

[Guidelines-oriented diagnostics of dyslipidemia]

T Kaiser1, J Thiery

  • 1Institut für Laboratoriumsmedizin, Klinische Chemie und Molekulare Diagnostik, Universitätsklinikum Leipzig, Liebigstr. 27, 04103, Leipzig, Deutschland. Thorsten.Kaiser@medizin.uni-leipzig.de

Herz
|October 12, 2012
PubMed

Insights

This article outlines diagnosing dyslipidemia in older adults, focusing on cardiovascular disease risk. It details risk assessment, LDL-C goal setting, and novel biomarkers for better patient management.

Area of Science:

  • Cardiology
  • Endocrinology
  • Clinical Diagnostics

Context:

  • Cardiovascular diseases (CVDs) are a leading cause of mortality in the elderly.
  • Altered lipid metabolism is a significant risk factor for CVDs.
  • Dyslipidemia is prevalent in aging populations.

Purpose:

  • To present a guideline-based approach for diagnosing dyslipidemia in elderly patients.
  • To define individualized low-density lipoprotein cholesterol (LDL-C) goals based on overall cardiovascular risk.
  • To incorporate additional cardiovascular risk factors beyond traditional charts and discuss innovative biomarkers.

Summary:

  • The diagnostic approach begins with evaluating overall cardiovascular mortality risk using current charts.
  • Individualized LDL-C targets are established based on this risk assessment.
  • The article explores supplementary risk factors and novel biomarkers for enhanced diagnostic value.

Impact:

  • Improved diagnostic strategies for dyslipidemia in older adults.
  • Personalized treatment goals to mitigate cardiovascular mortality.
  • Integration of advanced biomarkers into clinical practice for more accurate risk stratification.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...